Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Ther. class.
anesthetics topical local
antiarrhythmics
Indications
Action
Contraindicated in:
Resp: bronchospasm.
Assessment
Antiarrhythmic
• Monitor ECG continuously and blood pressure and respiratory status frequently
during administration
Anesthetic
Ther. class.
nonsteroidal anti inflammatory agents
nonopioid analgesics
Indications
Short-term management of pain (not to exceed 5 days total for all routes combined)
Contraindicated in:
• Hypersensitivity
GI: GI BLEEDING, abnormal taste, diarrhea, dry mouth, dyspepsia, GI pain, nausea.
Assessment
• Patients who have asthma, aspirin-induced allergy, and nasal polyps are at
increased risk for developing hypersensitivity reactions. Assess for rhinitis, asthma,
and urticaria
• Assess pain (note type, location, and intensity) prior to and 1–2 hr following
administration
Action
Patient/Family Teaching
• Instruct patient on how and when to ask for and take pain medication
• Instruct patient to take medication exactly as directed. Take missed doses as soon
as remembered if not almost time for next dose. Do not double doses. Do not take
more than prescribed or for longer than 5 days
ketamine
Ther. class.
general anesthetics
Indications
Contraindicated in:
• Hypersensitivity
• Psychiatric disturbances
• Hypertension
Action
Patient/Family Teaching
• Psychomotor impairment may last for 24 hr after anesthesia. Caution patient to
avoid driving or other activities requiring alertness until response to medication is
known
• Advise patient to avoid alcohol or other CNS depressants for 24 hr after anesthesia
propofol
Ther. class.
general anesthetics
Indications
• Maintenance of balanced anesthesia when used with other agents in children >2
months and adults
Contraindicated in:
Action
Patient/Family Teaching
• Inform patient that this medication will decrease mental recall of the procedure
• May cause drowsiness or dizziness. Advise patient to request assistance prior to
ambulation and transfer and to avoid driving or other activities requiring alertness for
24 hr following administration